The Trump-appointed federal judge who unilaterally ordered the FDA to revoke approval of an abortion drug allowed Idaho, Kansas and Missouri to move forward in another lawsuit over mifepristone.

The money brings Teal Health's total funding to $23 million as it prepares to launch the first FDA-approved cervical cancer product.

A Texas judge has allowed three states to move forward with a legal challenge seeking to impose stricter rules on the abortion pill mifepristone, reigniting the battle over medication abortion access in the U.

A federal judge in Texas is allowing three other states to pursue a challenge seeking to restrict access to the abortion pill mifepristone nationwide.

Serena Williams is supporting innovation in women’s health. Teal Health The tennis star has aligned herself with Teal Health, a women’s health startup founded by Kara Egan (CEO) and Dr. Avnesh Thakor in 2020.

I recently learned of Eli Lilly & Co.’s (“Lilly”) recent lawsuit against FDA from Nicole DeFeudis, who interviewed me for her Endpoints News

Roll Call reports that the newly finalized rule will allow for health care providers who have not seen a patient in person to prescribe six months’ worth of buprenorphine via telehealth. Also in pharma news: FDA's proposed nicotine crackdown;

“Basically, the farther the patients resided from an abortion facility, the more they were depending on the pills being mailed to them,” co-lead researcher Dr. Emily Godfrey, an OB/GYN and family doctor with the University of Washington, said in a news release.

The states want the federal Food and Drug Administration to prohibit telehealth prescriptions for mifepristone and require that it be used only in the first seven weeks of pregnancy instead of the current limit of 10 weeks.

Idaho, Kansas and Missouri can pursue legal action to prohibit the Food and Drug Administration from allowing online prescriptions.

A federal judge in Texas ruled that three states can challenge the current rules of accessibility for abortion pills.

In the final days of the Biden administration the Drug Enforcement Administration (DEA) has issued new regulations on who can prescribe controlled substances.  This is the agencies third attempt at a proposed rule on the topic.